GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Enorama Pharma AB (OSTO:ERMA) » Definitions » ROE % Adjusted to Book Value

Enorama Pharma AB (OSTO:ERMA) ROE % Adjusted to Book Value : -16.28% (As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Enorama Pharma AB ROE % Adjusted to Book Value?

Enorama Pharma AB's ROE % for the quarter that ended in Dec. 2024 was -424.02%. Enorama Pharma AB's PB Ratio for the quarter that ended in Dec. 2024 was 26.05. Enorama Pharma AB's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -16.28%.


Enorama Pharma AB ROE % Adjusted to Book Value Historical Data

The historical data trend for Enorama Pharma AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enorama Pharma AB ROE % Adjusted to Book Value Chart

Enorama Pharma AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.76 -29.95 -147.19 -26.92 -12.30

Enorama Pharma AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -43.20 -24.49 -18.59 -9.76 -16.28

Competitive Comparison of Enorama Pharma AB's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Enorama Pharma AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enorama Pharma AB's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Enorama Pharma AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Enorama Pharma AB's ROE % Adjusted to Book Value falls into.


;
;

Enorama Pharma AB ROE % Adjusted to Book Value Calculation

Enorama Pharma AB's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-320.44% / 26.05
=-12.30%

Enorama Pharma AB's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-424.02% / 26.05
=-16.28%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Enorama Pharma AB ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Enorama Pharma AB's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Enorama Pharma AB Business Description

Traded in Other Exchanges
N/A
Address
Vastra Varvsgatan 19, Malmo, SWE, SE-211 77
Enorama Pharma AB is a pharmaceutical company that focuses on consumer-friendly medicated chewing gum containing generic substances. It provides medicated gums containing generic pharmaceutical substances, developed through its ChewMed technology platform.

Enorama Pharma AB Headlines

No Headlines